科学文献
我们与学术机构开展合作研究，以评估我们的管线产品。以下是发表的相关文献。
年：
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to PI, IMiD and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice
MV Mateos, K Weisel, T Martin, JG. Berdeja, A Jakubowia […]
Five‑year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR‑B38M chimeric antigen receptor T cells in the LEGEND‑2 study: a case report
BY Wang, WH Zhao, YX Chen, XM Cao, Y Yang, YL Zhang, FX […]
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
Delforge M, Vekemans M, Depaus J, Meuleman N, Van De Ve […]
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Tom Martin, Saad Z. Usmani, Jordan M. Schecter, Tito Ro […]
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Adam D. Cohen, Parameswaran Hari, Myo Htut, Jesus G. Be […]